Source: International Congress 2019 – Advances in asthma pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Abohalaka (Ankara, Turkey), T. Bozkurt (Ankara, Turkey), E. Nemutlu (Ankara, Turkey), S. Onder (Ankara, Turkey), I. Sahin-Erdemli (Ankara, Turkey). The effect of endocannabinoid metabolism inhibition on airway inflammation in mice. 3878

Member's Comments

No comment yet.

Related content which might interest you: The effect of nicotine on COX-dependent airway relaxation and inflammatory mediator expression Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Reduction of endogenous acetylcholine contributes to pulmonary inflammation in a model of emphysema in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Gut microbial modulation attenuates emphysema development by suppressing inflammation and apoptosis Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Sirtuins inhibition modulates endotoxin-induced lung inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 The protective effects of SIGIRR on flagellin-induced acute inflammation of the airway in mice Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice Source: Eur Respir J 2015; 46: 1451-1460 Year: 2015 Alteration of eicosanoid metabolism/signalling in IL-9 overexpressing mice and impact on lung fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 575s Year: 2007 Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Modulation of chronic airway inflammation in guinea pigs by oral tolerance: effects in lung mechanics, cellular infiltration and nitric oxide production Source: Eur Respir J 2002; 20: Suppl. 38, 382s Year: 2002 Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 Role of Clara cell protein (CC)- 10 in the regulation of allergic airway inflammation and tolerance induction in mice Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008 LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007 Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 Effects of dehydrodieugenol on neuroinflammation and behavior changes in mice with mixed granulocytic chronic airway inflammation Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018